✦ LIBER ✦

Use of solubility analysis in pharmaceutical stability studies

✍ Scribed by J. P. Comer; L. D. Howell

Publisher: John Wiley and Sons
Year: 1964
Tongue: English
Weight: 252 KB
Volume: 53
Category: Article
ISSN: 0022-3549
DOI: 10.1002/jps.2600530322

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of models in determining chemical ph

Use of models in determining chemical pharmaceutical stability

✍ Lloyd Kennon 📂 Article 📅 1964 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

HE PHARMACEUTICAL industry has long been it affords the tablet ingredients which are ad-Tinterested in tablet coating for the protection versely affected b y environmental conditions, North Dakota State University, Fargo. taste, and for the elegant appearance i t provides Parke Davis and 80.. The Up

Use of an approximate dielectric constan

Use of an approximate dielectric constant in solubility studies

✍ Willis E. Moore 📂 Article 📅 1962 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

Use of differential scanning potentiomet

Use of differential scanning potentiometry in pharmaceutical analysis

✍ Ruben H. Manzo; Ernestina Luna; Daniel A. Allemandi 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB 👁 1 views

Prediction of stability in pharmaceutica

Prediction of stability in pharmaceutical preparations XI. Increased stability of soluble steroid hemiesters by steric hindrance

✍ Edward R. Garrett; Max E. Royer 📂 Article 📅 1962 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB

Preformulation studies II: Stability of

Preformulation studies II: Stability of drug substances in solid pharmaceutical systems

✍ J. Tingstad; J. Dudzinski 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB

Solubility advantage of amorphous pharma

Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis

✍ Sharad B. Murdande; Michael J. Pikal; Ravi M. Shanker; Robin H. Bogner 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 1 views

In recent years there has been growing interest in advancing amorphous pharmaceuticals as an approach for achieving adequate solubility. Due to difficulties in the experimental measurement of solubility, a reliable estimate of the solubility enhancement ratio of an amorphous form of a drug relative